Showing results (971-980 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|October 28, 1998
Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathyC Wikell, P B Bergqvist, S Hjorth, et al.Clinical Neuropharmacology|October 28, 1998
Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxinF Grandas, A Traba, F Alonso, et al.Clinical Neuropharmacology|October 28, 1998
Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal ScaleR B Rosse, S Johri, M Goel, et al.Clinical Neuropharmacology|August 1, 1989
Continuous oral administration of L-dihydroxyphenylalanine (L-DOPA) solution to patients with advanced Parkinson's diseaseJ P Bennett, M Turk, E LandowClinical Neuropharmacology|August 1, 1989
An open label trial of dextromethorphan in Huntington's diseaseF O Walker, V P HuntClinical Neuropharmacology|September 18, 2014
Comparison of effects of valsartan and amlodipine on cognitive functions and auditory p300 event-related potentials in elderly hypertensive patientsEiichi Katada, Norihiko Uematsu, Yuko Takuma, et al.Clinical Neuropharmacology|September 18, 2014
Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practiceAnastasia Orlova Lorentzen, Line Sveberg, Øyvind Midtvedt, et al.Clinical Neuropharmacology|January 1, 1986
Calcium channel antagonists and the treatment of migraineD A GreenbergClinical Neuropharmacology|September 19, 2013
Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?Pavel Golubchik, Arad Kodesh, Abraham WeizmanClinical Neuropharmacology|September 19, 2013
Acute treatment of trigeminal neuralgia with onabotulinum toxin ACarlos Zúñiga, Fabian Piedimonte, Sergio Díaz, et al.Pageof 236